InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by DST Capital LLC. Insider active across 1 company, notably Biostage, Inc.. Aggregated, 7 disclosures have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €2.6m. History available since 17 June 2021. The latest transaction was filed on 6 April 2023 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
62,500 shares@ US$6.0013.2% of flowCommon StockSEC:0001493152-23-011747:0
Ideal exit: 1 Jan 2024 (T+270)
7,000 shares@ US$2.000.5% of flowCommon StockSEC:0001415889-22-012350:0
8,277 shares@ US$5.922.1% of flowCommon StockSEC:0001104659-22-063025:0
Ideal exit: 6 Feb 2023 (T+270)
500,000 shares@ US$2.0037.7% of flowCommon StockSEC:0001104659-21-114301:0
Ideal exit: 29 May 2022 (T+270)
500,000 shares@ US$2.0032.5% of flowCommon StockSEC:0001104659-21-114301
Ideal exit: 29 May 2022 (T+270)
150,000 shares@ US$2.009.7% of flowCommon StockSEC:0001104659-21-083662
Ideal exit: 14 Mar 2022 (T+270)
150,000 shares@ US$2.0011.2% of flowCommon StockSEC:0001104659-21-083662:0
Ideal exit: 14 Mar 2022 (T+270)
7 of 7 declarations
About DST Capital LLC
DST Capital LLC is a director and insider at Biostage, Inc.
